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ABSTRACT 
AIM: To estimate the number of children living with cerebral palsy (CP) in England & Wales 
in 2013 by severity and to extrapolate this figure to 2020. 
METHOD: Data from the North of England Collaborative Cerebral Palsy Survey for births 
during 1991-2000 were restricted to individuals aged ≥3 years to estimate the prevalence of 
CP and to calculate 15-year survival by severity according to the number of severe 
impairments and lifestyle assessment score. The number of 3-15-year olds with CP of 
different severity in England & Wales was estimated in 2013 and 2019 using actual and 
nationally projected births.  
RESULTS: Cumulative survival estimates up to age 16 years in children with CP differ 
significantly by severity ranging between 97-100% for children with non-severe CP and 
between 64-67% for those with most severe CP. By the end of 2013, the estimated number 
of children aged 3-15 years living with CP in England & Wales will be about 20,500 rising to 
approximately 22,100 by 2020, a 7.5% increase. 
INTERPRETATION: The number of children living with CP in England & Wales will increase by 
2020 due to an increasing population. This will have significant implications for health and 
social care service planning. 
 
Short title (up to six words): predicted prevalence of CP by severity 
What this paper adds?  
 15-year survival rates in children with CP differ significantly by severity being the 
lowest (between 64-67%) for those with most severe CP. 
 We estimate that by 2020, there will be approximately 22,100 children aged 3-15 
years living with CP in England & Wales, around two thirds of them with moderate or 
severe CP.  
 There will be a 7.5% estimated increase in the total number of 3-15 year-old children 
living with CP in England & Wales by 2020 which should be taken into consideration 
when planning health and social care services. 
 
Keywords: cerebral palsy prevalence, severity, survival, projected estimates, North of 
England Collaborative Cerebral Palsy Survey (NECCPS) 
 
ABBREVIATIONS 
CI  Confidence interval 
CP  Cerebral palsy 
HR  Hazard Ratio 
LAS  Lifestyle Assessment Score 
NECCPS North of England Collaborative Cerebral Palsy Survey 
ONS  Office for National Statistics 
SCPE  Surveillance of Cerebral Palsy in Europe 
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The improvement of health, wellbeing and quality of life of all children in the UK is a public 
health priority, as reflected by recent government documents, including the Children and 
Families Act 2014 (http://www.legislation.gov.uk/ukpga/2014/6/contents/enacted). 
Disabled children and those who have special educational needs, in particular, require an 
effective system of identification and monitoring in each region in order to allocate 
appropriate resources to support health and social care service planning. However, there is 
limited data available on the number of disabled children by region and limited 
understanding of their met and unmet needs,1 especially by specific medical condition. 
Cerebral palsy (CP) is a common cause of childhood disability. During the last three 
decades, the overall prevalence of CP has remained relatively stable over time and across 
countries, ranging between 2 and 3.5 per 1000 live births.2-7 Children with CP have a much 
higher mortality rate compared to children without CP, which is mostly attributed to children 
with severe impairments.7-10 Evidence regarding improvement in CP survival over the last 
three decades is inconsistent, with increasing survival in some countries10 but not in 
others.8,9,11 
Children with CP, particularly those with one or more severe impairments (motor, 
sensorial and/or intellectual) and/or associated conditions, have specific health and social 
care needs (e.g. spinal/orthopaedic surgery, need for mobility aids, respiratory support, 
physiotherapy, speech and language therapy, occupational therapy, medications, social 
workers) and often special education needs which differ depending on the type and severity 
of impairments. Therefore, in order to inform the planning of health and social care services 
and to assign the appropriate resources, it is important to estimate the number of children 
with CP of different severity for each region. Although in England, the Family Resources 
Survey annually estimates the population disability prevalence, including children, it does 
not provide estimates by medical condition.12 
The aim of this study is to estimate the number of children living with CP in England & 
Wales in 2013 by severity and to extrapolate this figure to 2020 to provide evidence for 
health and social care planning. 
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METHOD 
 
Study birth population 
Data for cases of CP occurring in births between 1 January 1991 and 31 December 2000 were 
extracted from the prospective population-based survey of CP, the North of England 
Collaborative Cerebral Palsy Survey (NECCPS), in December 2015. The North of England is a 
geographically defined area (comprising counties of North Cumbria, Northumberland, Tyne 
& Wear, Durham and Darlington, and Teesside) with a stable population of almost three 
million and approximately 32,000 births/year, characterised by a relatively low percentage 
of minority ethnic groups [about 5% in 2011, Office for National Statistics (ONS) data].  
NECCPS prospectively recorded infants with CP born to mothers resident in the 
Northern Region from 1991 (data collection ceased on 31st March 2016). Details of case 
ascertainment and data notification are described elsewhere6 and in Box 1.  
For this analysis, cases due to a known post-neonatal insult were excluded resulting in 
cases with congenital CP only. All analyses were restricted to children with CP aged ≥3 years 
to acknowledge that deaths due to CP prior to this age were likely to be underreported,8 and 
because the severity information for these young children was mostly missing.  
 
Classification and Definitions 
NECCPS uses the Little Club definition of CP, updated by Bax,13 and, as a member of the 
Surveillance of Cerebral Palsy in Europe (SCPE) collaboration, follows the SCPE inclusion 
criteria14 (Box 1). 
CP severity used for the survival analysis was classified using two types of 
measurements: 1) the number of severe impairments (a) lower limb, b) upper limb, c) 
intellectual, d) vision and e) hearing impairments); 2) a measure of impact of disability on 
the child and family, the lifestyle assessment questionnaire, a specific NECCPS severity 
measure. We used binary categories ‘severe’ and ‘not severe’ to classify impairment 
variables recorded at age five years. The impairment was defined as severe if the child: a) 
was unable to walk without aids; b) was unable to self-dress (e.g. to put on a T shirt); c) had 
severe or profound intellectual disability (IQ <50); d) was blind or had no useful vision; e) 
had profound or severe loss of hearing (> 70db).6,15  
The lifestyle assessment questionnaire covers six dimensions: physical independence, 
mobility, clinical burden, schooling, economic burden, and social integration, from which a 
global lifestyle assessment score (LAS) is derived.16 The LAS is expressed as a percentage, 
with a maximally disadvantaged child scoring 100%. We defined children with LAS<30% as 
having mild impairment, LAS=30-69% as moderate and LAS≥70% as severe impairment as 
defined in previous research.6 A typical child with a LAS of <30% completes most but not all 
self-help activities alone, attends mainstream school with some assistance and has minimal 
additional needs; whereas a typical child with a ≥70% score undertakes only a few self-help 
activities, requires specialised education and health and social care resulting in substantial 
economic and social burden for society and the family. Children who died before the LAS 
was measured were included in the most severe group (≥70%). 
 
 
Statistical analysis 
The number of live births for England & Wales by region and year of delivery for 1998-2013 
was obtained from the ONS published data (e.g. for 2013 ‘Child Mortality Statistics, 2013’17) 
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as were projected births for 2014-2016.18 The number of children that reached age 3 years 
old between 2001-2019 was estimated by applying the national survival rates to the number 
of live births by region conditional to the year of birth (supplementary Figure I). As the 
number of deaths was available for the age groups <1 (85% of all deaths at <5 years) and 1-4 
years only, we assumed that the percentage of deaths in children aged 1-2 and 3-4 years was 
equal (50%). For example, there were 635,549 children born in England and Wales in 1998, 
of whom we estimated 631,446 (99.4%) would reach age 3 in 2001. 
The average prevalence of CP in the 3-year olds delivered during 1991-2000 in the 
North of England (NECCPS data) was calculated per 1000 3-year old children. Trends in CP 
prevalence over time were examined using Poisson regression adjusted for year of birth and 
severity. As there was no evidence of any temporal trends (data not shown), we used the 
average prevalence in the North of England (for those who turned 3 years old during 1994-
2003) to estimate the number of children with CP who reached 3 years old between 2001-
2019, in each region.  
Kaplan-Meier survival probability for two-year survivors with CP (NECCPS data) was 
calculated up to the 16th birthday according to CP severity (by number of severe 
impairments and by LAS) and the survival curves were plotted. Differences in survival 
between severity groups were assessed using the log-rank test.19 Cox regression, with year 
as a continuous explanatory variable, was performed to examine linear trends in survival of 
those who reached age 3 during 1994-2003. To calculate the number of 3-15 year olds living 
with CP by 2014 and by 2020, we multiplied Kaplan Meier survival probabilities by the 
estimated number of children with CP who reached age 3 between 2001-2013 and between 
2007-2019, overall and by severity. For example, to calculate the number of individuals alive 
by 2014, we used the 15 year survival rate for cases born during 1998-2002, the 10 year 
survival rate for cases born during 2003-2007 etc.  
SPSS 21.0 (IBM Corporation, NY, USA) was used for the survival analysis and GraphPad 
Prism v 5.01 was used to plot the survival curves. Poisson regression was performed using 
STATA 14.1 (Statacorp, College Station, TX, USA). P<0.05 was considered statistically 
significant.  
 
Ethics approval 
For this study we used anonymised data of children recorded on the NECCPS. The NECCPS 
has ethics permission, which includes permission to analyse anonymised data. Parents give 
permission for their child's name to be on the database and reports of analysis of 
anonymised data to be undertaken. Parents know what data are held about their child and 
contribute to the NECCPS data by completing a questionnaire. 
 
RESULTS 
 
Out of an estimated 339,009 children born during 1991-2000 in the North of England and 
who reached their third birthday between 1994-2003, there were 875 children with 
congenital CP registered in the NECCPS, giving an average CP prevalence in 3-year olds of 
2.58 (95% CI 2.41-2.76) per 1000. 
Table I shows the number of deaths in children aged 3-15 years old and the cumulative 
survival percentage in children with CP in different severity groups using two severity 
measurements (NECCPS data). Children with the most severe CP, i.e. with ≥3 severe 
impairments and with LAS≥70%, constituted a similar proportion of children, 16.6% and 
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19.4% respectively (Fisher exact test of proportions, p=0.14). The mortality rates up to the 
first 16 years of life were the highest in these groups of children.  
The survival curves of children with CP by severity who were alive at age three years 
are presented in Figure 1. The 15-year survival percentages for children with no or one 
severe impairment or with LAS<70% ranged between 97-100%. The 15-year survival 
percentages for children with severe CP were the lowest at about 63.5% in children with ≥3 
severe impairments and 66.5% for those with LAS≥70% (Fig 1 and Table I), all much lower 
than for those with less severe CP (log-rank Mantel-Cox test p<0.0001). Survival did not alter 
significantly over the study period, overall (Hazard ratio [HR]=0.95, 95% CI 0.87-1.03; p=0.22) 
or after adjustment for severity (HR=0.98, 95% CI 0.89-1.07; p=0.61). 
Table II shows the total estimated number of 3-15 year-old children living with CP in 
England & Wales and by English region by 2014, the estimated number of children aged 3-15 
years with at least one severe impairment (44.7% of all 3-15 year-olds with CP in England & 
Wales), with moderate or severe CP (LAS≥30%, 65.7%) and with severe CP (LAS≥70%, 15.3%). 
Supplementary Table I shows the estimated prevalence of CP by severity in children aged 3-
15 years in England & Wales by 2020 (per 1000 children aged 3-15 years). By 2014, 1509 
children with CP in England & Wales (7.3% of all aged 3-15 years), 661 (7.2%) of children 
with at least one severe impairment, 982 (7.3%) of children with LAS≥30% and 210 (6.7%) of 
children with LAS≥70% were estimated to have approached the age of 16 years, when 
transition from child to adult services begins for many children.  
By the beginning of 2020, we estimate there will be 22,077 children aged 3-15 years 
living with CP in England & Wales, a 7.5% increase compared to 2013 (Table II). Nearly half of 
these children (n=9,869, 44.7%) will have at least one severe impairment, 65.6% (n=14,493) 
will have moderate or severe CP (LAS≥30%) and 15.3% (n=3,375) severe CP (LAS≥70%). In 
England & Wales, 666 children with at least one severe impairment, 988 children with 
moderate or severe CP (LAS≥30%) and 212 children with severe CP (LAS≥70%) will be 
approaching 16 years of age by 2020. 
 
DISCUSSION 
To our knowledge, this is the first study that reports the estimated number of children with 
CP aged 3-15 years in England & Wales and extrapolates this data to predict numbers by 
2020. Using population-based register data in the North of England, we found that 15-year 
survival in children with CP differed significantly by severity, ranging between 97-100% for 
children with non-severe CP and between 64-67% for those with severe CP irrespective of 
severity measurement. By 2020, we estimate there will be approximately 22,100 children 
aged 3-15 years living with CP in England & Wales, around two thirds of them with moderate 
or severe CP, a group of children who need access to specialised health and social care 
services. The information on the number of children with CP reaching 16 years of age is 
important for planning transition of these children to adult health care services.  
Our findings on the CP prevalence and survival of children with CP of different severity 
are consistent with previously reported differences by severity in both children and 
adults.3,5,8-10,20 The novel aspect of the study are the predicted CP population prevalence 
rates and the estimated number of children with CP of various severity in England & Wales 
by 2020.  
Our study benefits from the inclusion of population-based data from a well-established 
prospective CP register, NECCPS, in a well-defined geographical area. A major strength of the 
NECCPS is that it is based on a longstanding collaboration of local clinicians from all 15 
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geographical districts in the region. High case ascertainment is ensured as cases were 
notified from multiple sources via the regional network of interested clinicians, and data 
records were held at the Regional Maternity Survey Office on a single database linked to 
other regional registers. We deliberately restricted our data collection to a single register, 
acknowledging the advantages of consistent inclusion criteria and unique variables collected 
by the NECCPS which capture the impact of CP on the child and family, the lifestyle 
assessment questionnaire. We used two measures of CP severity, including LAS, and found 
very similar survival between these measures, which supports the robustness of our survival 
estimates. We used ONS projected births, which are based on fertility, mortality and 
immigration rates, to more reliably estimate the number of children with CP. Additionally, 
we accounted for changes in survival over time by using 15 year survival relating to children 
born during 1998-2002 and 10 year survival for children born between 2003-2007 etc. 
However, our study has some limitations. We applied the North of England CP 
prevalence and survival rates to estimate the number of children living with CP in different 
regions in England & Wales assuming a stable CP prevalence over time and equal survival 
trends across regions, although regional differences have been reported.8 However, the 
stable children disability rate in the UK over the last few years12 and the relative stability of 
CP rates from the early 1990s, in particular for term births, and across countries5,6,21 in 
addition to lack of evidence in relation to improvement in the survival over time,8,9,11 suggest 
that an error in estimation of the number of children with CP resulting from temporal 
changes would be marginal. We restricted our survival analysis to CP cases delivered during 
1991-2000 as firstly, we would not have achieved a sufficiently long follow up period for the 
15-year survival if we used more recent data, and secondly, for 2001-2010, there was an 
apparent under-ascertainment of CP cases to the NECCPS, which would have resulted in an 
underestimation of CP prevalence. Although this reduced the number of cases included in 
the survival analysis, it ensured that the data used were based on high completeness of case 
ascertainment. The NECCPS system of death ascertainment warranted that all deaths of 
children in our cohort living in the region were identified up to 2014. Deaths that occurred 
among children who were not flagged with the National Health Services Central Register for 
England (born in 2000) and moved out of region might have been missed, but this under-
ascertainment likely applies to very few cases. Another limitation was a relatively high 
percentage (nearly 20%) of cases with missing severity information based on the lifestyle 
assessment questionnaire compared to 6% in the severity measurement based on the 
number of severe impairments. In fact, only 5% (n=47) of survivors at two full years have 
missing severity information based on both measurements. Other cases with missing LAS 
have the number of impairments recorded which gives a good indication of severity in this 
group (41% with no severe impairment, 17% with one, 6% with two and 9% with ≥3 severe 
impairments). 
Although a focus of this study is congenital CP, children with post-neonatally acquired 
CP, who account for about 5-10% of all CP cases,7,22 will have similar needs that need to be 
taken into account when planning services and resources. 
Our predictions can be used to estimate the costs associated with specialised health 
and social care services utilised by children with CP. This is of particular importance in light 
of current cuts in health and social care services due to austerity policies. While an 
estimation of costs was beyond the scope of this study, we conducted a review of literature 
published over the last two decades that estimated the economic costs of CP. We found that 
there was no universally agreed approach to medical and social care cost estimation of a life-
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long condition such as CP. The identified studies, most based outside Europe, used different 
approaches and varying types of estimated costs which resulted in a large variation in care 
costs estimates for individuals. The two European studies identified (a Dutch cost-of-illness 
study for intractable spastic CP in children23 and a Danish study quantifying lifetime costs of 
CP24) were in agreement that the largest cost component was non-medical cost during 
childhood. Additionally, we found no published studies in the UK that estimated the 
economic costs of care for children with CP. However, health and social care annual costs for 
young adults (aged 18-25 years) with CP in the UK were estimated to be £7,900 (2005 prices) 
per person.25 When costs for formal (paid) personal assistance were included, the annual 
costs per person were estimated to be almost twice as high (£14,500) resulting in 74.3 
million and 136.6 million total annual health and social care costs respectively.25  
 
CONCLUSION 
The study estimates that by 2020, the predicted number of children aged 3-15 years living 
with CP in England & Wales will be about 22,100, a 7.5% increase compared to 2013. 45% of 
these children will have at least one severe impairment and two thirds will have moderate or 
severe CP. This information is important for health and social care service planning. 
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Box 1. Definition of cerebral palsy (CP), inclusion criteria according to the Surveillance of 
Cerebral Palsy in Europe (SCPE) collaboration and detail on case and death ascertainment in 
the North of England Collaborative Cerebral Palsy Survey (NECCPS) 
Definition: NECCPS uses the Little Club definition of CP, updated by Bax,13 ('a disorder of 
posture and movement due to a defect or lesion in the immature brain') and complies with 
the SCPE consensus definition with the following key elements: cerebral palsy is a group of 
disorders—i.e., it is an umbrella term; it is permanent but not unchanging; it involves a 
disorder of movement, posture, or both, and of motor function; it is caused by a non-
progressive interference, lesion, or abnormality in the developing or immature brain.  
CP is classified according to the agreement of SCPE: spastic CP (unilateral or bilateral), 
dyskinetic and ataxic. 
Inclusion criteria: born to mothers resident in the North of England during 1991-2000, cases 
with congenital CP, i.e. not associated with a known post-neonatal insult, only included. 
Case and death ascertainment: Cases were notified to the NECCPS by District Convenors, 
that is consultant community paediatricians, who coordinated services for such children and 
received information about children needing services from other paediatricians, paediatric 
neurologists, physiotherapists, speech therapists and the regional child development centre. 
The convenor completed a notification form. Further details were forwarded to the survey 
when the child reached 5 years of age to confirm the diagnosis and provide details of 
associated impairments. Further, parents were invited to return the lifestyle assessment 
questionnaire which recorded the impact of the CP on the child and family.6 Data records 
were maintained and held at the Regional Maternity Survey Office on a single database 
linked through the mother’s details to prospective Perinatal Mortality Survey and Northern 
Congenital Abnormality Survey. 
Every case of CP mentioned on a child death certificate and every case mentioned as co-
morbidity on a late notification of a congenital anomaly is ascertained by the survey.6 Local 
child deaths (up to 18 years) were matched with the NECCPS records both from local data 
collection and annually from the ONS. In addition, up to 2014, a list of children on the 
register aged <16 years (with consent for contact), has annually been submitted to the 
National Strategic Tracing Service (NSTS) batch tracing service to identify any deaths from 
summary care record system before inviting families for the NECCPS study days. In addition, 
for deliveries during 1991-1999, the persons on the register were flagged with the National 
Health Services Central Register for England and notifications of deaths were sent to the 
approved researcher up to 2010 inclusive. 
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Table I: Survival up to age 16 years in children with cerebral palsy (CP) aged ≥3 years by severity using two severity measures (number of 
severe impairments and lifestyle assessment score), North of England, 1991-2000 births 
Severity 
measurement/ 
Age (years) 
Number of deaths and cumulative survival percentage of children with CP 
– n deaths (% surviving) 
 
3-5 6-10 11-15 Alive at 16+ years Total n  
By number of severe impairments    
None 1 (99.8) 0 (99.8) 1 (99.5) 404 (99.5) 406 
One 1 (99.4) 1 (98.9) 0 (98.9) 176 (98.9) 178 
Two 0 (100.0) 2 (97.8) 1 (96.7) 87 (96.7) 90 
Three and more 19a (86.9%) 20 (73.1) 14 (63.5) 92 (63.5) 145 
Missing  0a 3 (94.6) 2 (91.1) 51 (91.1) 56 
By lifestyle assessment score (LAS)    
<30% 0 (100.0) 0 (100.0) 0 (100.0) 112 (100.0) 112 
30-69% 1 (99.8) 1 (99.5) 4 (98.6) 414 (98.6) 420 
≥70% 20a (88.2) 25 (73.5) 12 (66.5) 113 (66.5) 170 
missing 0a  0 (100.0) 2 (98.8) 171 (98.8) 173 
Total 21 26 18 799 875 
aThose with missing severity data who died aged 3-5 years (n=9) were included in the most severe category (with ≥3 severe impairments or 
LAS≥70%); the group with ≥3 severe impairments contained 127 children with both severe walking and intellectual disability (inability to walk 
without aids and IQ<50) and at least one other severe impairment, eight children with severe walking disability and two other severe 
impairments (upper limb and/or vision or hearing) but not severe intellectual disability, and one child with severe intellectual disability and 
severe upper limb and vision impairments, but not severe walking disability.  
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Table II: Estimated number of children with cerebral palsy (CP) aged 3-15 years – total and for different severity categories – for England & Wales and by English 
region by 2014 and by 2020 
 England Wales England & 
Wales 
North East North 
West 
Yorkshire 
and the 
Humber 
East 
Midlands 
West 
Midlands 
East  London South East South 
West 
Children aged 3-15              
by 2014a 7980713 426156 8406870 365758 1056524 786177 637841 855211 847621 1493418 1242611 695553 
by 2020 8598921 445104 9044025 383064 1120477 840366 687838 915796 915155 1658234 1326849 751243 
Estimated children 
with CP aged 3-15 
yearsb 
            
by 2014 19494 1041 20535 893 2580 1920 1558 2089 2070 3650 3035 1699 
by 2020 20991 1086 22077 935 2735 2051 1679 2235 2234 4049 3239 1834 
Estimated children 
with CP with ≥1 
severe impairmentc 
            
by 2014 8720 465 9186 399 1154 859 697 934 926 1633 1357 760 
by 2020 9384 485 9869 418 1222 917 751 999 999 1811 1448 820 
Estimated children 
with moderate or 
severe CP 
(LAS≥30%) 
            
by 2014 12802 683 13485 586 1694 1261 1023 1372 1360 2397 1993 1116 
by 2020 13780 713 14493 614 1795 1346 1102 1467 1467 2659 2126 1204 
Estimated children 
with severe CP 
(LAS≥70%) 
            
by 2014 2990 159 3149 137 395 295 239 320 318 561 465 261 
by 2020 3209 166 3375 143 418 313 257 342 342 620 495 281 
aThe number of children aged 3-15 years by 2014 and by 2020 was estimated for deliveries during 1998-2010 and 2004-2016 respectively using ONS data on live 
births and survival for children aged 0-2 years.  bestimated using the percentage of children with CP of different severity (for children aged 3-15 years) and North 
of England survival rates up to age 16, by severity. clower limb, upper limb, intellectual, vision and hearing impairments are included; cases with missing severity 
data (6.4%) are not included in this estimation. LAS=lifestyle assessment score.  
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FIGURE LEGENDS 
Figure 1: 15-year survival of children with cerebral palsy aged ≥3 years (censored at 16 
years) by a) number of severe impairments, b) lifestyle assessment score (LAS) 
Figure footnote: a) Those who died aged 3-5 years (n=9) were included in the most severe 
category (with ≥3 severe impairments, 16.6% of all two-year survivors with CP).). Number of 
severe impairments: none (n=406, 2 deaths between 3-15 years), one (n=178, 2 deaths); two 
(n=90, 3 deaths), ≥3 (n=145, 53 deaths, including 9 aged 3-5 years with missing severity 
information), missing (n=56, 5 deaths at 6-15 years). 
b) LAS<30% (mild – n=112, no deaths between 3-15 years), LAS=30-69% (moderate – n=420, 
6 deaths) and LAS≥70% (severe – n=170 (19.4%), 57 deaths, including 9 deaths aged 3-5 
years with missing severity data), missing (n=173, 2 deaths at 11-15 years). 
 
Supplementary Figure 1: The number of children surviving to age 3 years in England & Wales 
born during 1998-2020* 
*for 1998-2013 the calculation is based on the actual number of live births and the survival 
estimates (obtained from the Office for National Statistics (ONS) published tables), for the 
years 2014 and beyond the ONS projected births were used. 
 
 
15 
Figure 1 
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Supplementary Figure 1: The number of children surviving to age 3 years in England & Wales 
born during 1998-2016* 
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Supplementary Table I: Estimated prevalence of cerebral palsy by severity in children aged 
3-15 years in England & Wales by 2020 (per 1000 children aged 3-15 years)  
 
Severity 
measurement 
 Estimated children with cerebral 
palsy aged 3-15 years by 2020 
Cerebral palsy prevalence in 
children 3-15 years*(per 
1000) (95% CI) 
By number of severe impairments  
None 10794 1.19 (1.17-1.22) 
One 4702 0.52 (0.51-0.54) 
Two 2351 0.26 (0.25-0.27) 
Three and more 2817 0.31 (0.30-0.32) 
Missing  1413 0.16 (0.15-0.16) 
By lifestyle assessment score (LAS)  
<30% 2988 0.33 (0.32-0.34) 
30-69% 11118 1.23 (1.21-1.25) 
≥70% 3375 0.37 (0.36-0.39) 
missing 4596 0.51 (0.49-0.52) 
Total  22077 2.44 (2.41-2.47) 
*Estimated using the predicted number of children with CP by severity category and the 
population of children aged 3-15 years in England &Wales by 2020 (n=9,044,025, Table II). 
 
 
